Head-to-head · WeighScore
Get Thin MD vs Pallas Health
By GLP-1 ScorecardUpdated
Score comparison
Pallas Health has the higher recorded score — 69.3/100 to 66.7/100.
Pallas Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Pallas advertises four-week renewal or an annual option for compounded injections. Ask for the full amount due and confirm when a prescribed order becomes final.
Before you choose
Get Thin MD does not publish a semaglutide price, so its Get Thin MD review sets out what it does disclose, while the Pallas Health review explains the conditions attached to Pallas Health's figure. The semaglutide cost page compares published rates across the field. Ask Get Thin MD for a written total before treating either one as the cheaper choice.
If neither one fits, Get Thin MD vs PauseRX and Heally vs Pallas Health compare each of them with another graded program, and the list of alternatives to Get Thin MD ranks the programs closest to Get Thin MD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the PlexusDx review covers one graded close to these two, at 67.7/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Get Thin MD | Pallas Health |
|---|---|---|
| WeighScore | 66.7/100 | 69.3/100 |
| Grade | C | C |
| Site position | #197 | #142 |
| Semaglutide | Confirm selected membership quote | $139 first period, then $199 every four weeks (compounded; confirm selected quote) |
| Tirzepatide | Confirm selected membership quote | $179 first period, then $299 every four weeks (compounded; confirm selected quote) |
| Coverage | Confirm coverage for your state | Confirm treatment and visit requirements for your state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Membership terms describe included medication, supplies and shipping
What to consider
- The terms and refund policy describe different first-payment triggers
- The refund policy requires 72 hours’ notice before renewal
Strengths
- Publishes first-period and four-week renewal amounts
- Explains when the charge is triggered and how to cancel future renewal
- Terms link to a pharmacy partner directory
What to consider
- Annual monthly equivalents do not establish the selected debit
- Once prescribed, the current cycle ordinarily is not prorated or refunded
- The six-month promise has separate eligibility and timing requirements
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.